training program on exercise tolerance, aerobic capacity, and quality of life in patients with systemic lupus erythematosus. Of the 172 patients, 151 (88%) were women and 161 (94%) were white, with a mean (SD) age at diagnosis of 58.3 (16.7) years. The average age-and sex-adjusted annual incidence for 2006-2015 was 5.9 per 100,000 population (95% CI 4.4-7.4), and overall incidence for the entire period was 5.8 (95% CI: 4.9-6.6) per 100,000. Incidence was 2 to 7 times higher in females compared to males in the different age classes (5.9 times higher on average), and increased progressively with age, culminating at 19.6 per 100,000 in females aged 65-74 years, with a slight decline thereafter to 15.9 per 100,000 among females aged 75 years and older. The incidence increased with calendar time over the 40-year period (p=0.005, figure) . There was no apparent seasonality in the incidence of pSS, with similar number of cases diagnosed during all four seasons. There was no difference in mortality in the pSS cohort compared to expected (standardized mortality ratio 1.15, 95% CI 0.86-1.50).
Conclusions:
The average annual incidence of pSS in this population basedcohort was 5.8/100,000, with a progressive increase over the 40 years of the study. Overall survival of pSS patients was not different from the general population.
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